TRENDSPOTTER: M&As with omics Firms May Be Valid Option for Pharmas Craving Pipeline Boost | GenomeWeb

Despite a decade of mega-mergers in the pharma industry, a significant productivity gap and a paucity of new blockbuster drugs has fueled a rapid contraction in growth in the sector from double to single digits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.